Literature DB >> 31993975

Hip resurfacing as an outpatient procedure: a comparison of overall cost and review of safety.

M D Gaillard-Campbell1, C Fowble2, L Webb2, T P Gross2.   

Abstract

Recent advancements in arthroplasty surgical techniques and perioperative protocols have reduced the duration of hospitalization and length of recovery, allowing surgeons to perform joint replacement as an outpatient procedure. This study aims to evaluate the cost-effectiveness and safety of outpatient hip resurfacing. Two experienced surgeons performed 485 resurfacing surgeries. We retrospectively compared clinical outcomes and patient satisfaction with published outpatient total hip results. Furthermore, we compared average insurance reimbursement with that of local inpatient hip replacement. No major complications occurred within 6 weeks. Of the 39 patients with previous inpatient experience, 37 (95%) believed their outpatient experience was superior. The average reimbursement for hip arthroplasty at local hospitals was $50,000, while the average payment for outpatient resurfacing at our surgery center was $26,000. We conclude that outpatient hip resurfacing can be accomplished safely, with high patient satisfaction, and at a tremendous financial savings to the insurer/patient. LEVEL OF EVIDENCE: III.

Entities:  

Keywords:  Hip replacement; Hip resurfacing; Minimally invasive; Outpatient; Total hip arthroplasty

Year:  2020        PMID: 31993975      PMCID: PMC7960592          DOI: 10.1007/s12306-020-00637-z

Source DB:  PubMed          Journal:  Musculoskelet Surg        ISSN: 2035-5114


  17 in total

1.  Does computer-assisted surgery improve accuracy and decrease the learning curve in hip resurfacing? A radiographic analysis.

Authors:  Thorsten M Seyler; Lawrence P Lai; Denise I Sprinkle; William G Ward; Riyaz H Jinnah
Journal:  J Bone Joint Surg Am       Date:  2008-08       Impact factor: 5.284

2.  The learning curve for adopting hip resurfacing among hip specialists.

Authors:  Ryan M Nunley; Jinjun Zhu; Peter J Brooks; C Anderson Engh; Stephen J Raterman; John S Rogerson; Robert L Barrack
Journal:  Clin Orthop Relat Res       Date:  2010-02       Impact factor: 4.176

3.  Outpatient surgery as a means of cost reduction in total hip arthroplasty: a case-control study.

Authors:  Michael Aynardi; Zachary Post; Alvin Ong; Fabio Orozco; Dean C Sukin
Journal:  HSS J       Date:  2014-07-12

4.  Current status of modern fully porous coated metal-on-metal hip resurfacing arthroplasty.

Authors:  Thomas P Gross; Fei Liu
Journal:  J Arthroplasty       Date:  2013-05-13       Impact factor: 4.757

5.  Minimally invasive outpatient total hip arthroplasty: a financial analysis.

Authors:  Kim C Bertin
Journal:  Clin Orthop Relat Res       Date:  2005-06       Impact factor: 4.176

6.  Five year results of the first US FDA-approved hip resurfacing device.

Authors:  Edwin P Su; Lawrence R Housman; John L Masonis; John W Noble; C Anderson Engh
Journal:  J Arthroplasty       Date:  2014-03-28       Impact factor: 4.757

7.  Rapid rehabilitation and recovery with minimally invasive total hip arthroplasty.

Authors:  Richard A Berger; Joshua J Jacobs; R Michael Meneghini; Craig Della Valle; Wayne Paprosky; Aaron G Rosenberg
Journal:  Clin Orthop Relat Res       Date:  2004-12       Impact factor: 4.176

8.  Femoral neck fractures after metal-on-metal total hip resurfacing: a prospective cohort study.

Authors:  David R Marker; Thorsten M Seyler; Riyaz H Jinnah; Ronald E Delanois; Slif D Ulrich; Michael A Mont
Journal:  J Arthroplasty       Date:  2007-10       Impact factor: 4.757

9.  Outpatient minimally invasive total hip arthroplasty via a modified Watson-Jones approach: technique and results.

Authors:  Darwin Chen; Richard A Berger
Journal:  Instr Course Lect       Date:  2013

10.  Newer anesthesia and rehabilitation protocols enable outpatient hip replacement in selected patients.

Authors:  Richard A Berger; Sheila A Sanders; Elizabeth S Thill; Scott M Sporer; Craig Della Valle
Journal:  Clin Orthop Relat Res       Date:  2009-02-28       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.